Open Label Extension for GLYX13-C-202, NCT01684163

Clinical trial NCT02192099 · TERMINATED

Trial details

NCT number: NCT02192099
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2014-09-08
Primary completion: 2018-11-08
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.